HOTH
Hoth Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Hoth Therapeutics (HOTH) Stock: Buy, Sell, or Hold?
$1.36
+0.65 (+92.01%)
â˛
5d:
+126.67%
30d:
+74.36%
90d:
+28.3%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
40/100
Position
FAIR
Forward P/E & Valuation
-1.9x
Next 12M consensus est.
Wall Street Target
$5.00
+267.6% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.54 / $0.70
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: HOTH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When HOTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: HOTH is currently trading at $1.36, which is considered fair based on recent price action.
Technical Outlook: Technically, HOTH is in a strong downtrend. The price is approaching resistance at $0.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 92.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+267.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HOTH is in a strong downtrend. The price is approaching resistance at $0.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 92.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+267.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
40/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
74.7%
Trading Range & Key Levels
Support Level
$0.54
Resistance Level
$0.70
Current Trend
Strong Downtrend
Technical data as of
May 21, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+92.0%)
- BULLISH: Trading 267.6% below Wall St target ($5.00)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.94
Wall Street Target
$5.00
(+267.6%)
Share HOTH Analysis
Share this live HOTH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (HOTH)
Bullish
18 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
17 msgs
24h retail stream
Last Tracked
May 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Hoth's pivot from biotech to space tech has sparked a massive rally in the stock, with traders bullish on the new direction and the importance of securing fresh deals.
Key Retail Themes:
Company's pivot to space tech
Importance of securing new deals
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:17 PM ET
Data refreshes hourly during market hours. Next update: 3:17 PM
Data refreshes hourly during market hours. Next update: 3:17 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HOTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 35 SELL |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive HOTH Research Pages
